Non-Surgical Periodontal Therapy Could Improve the Periodontal Inflammatory Status in Patients with Periodontitis and Chronic Hepatitis C

Dorin Nicolae Gheorghe, Dora Maria Popescu, Alex Salan, Mihail Virgil Boldeanu, Claudiu Marinel Ionele, Allma Pitru, Adina Turcu-Stiolica, Adrian Camen, Cristina Florescu, Ion Rogoveanu, Petra Surlin, Dorin Nicolae Gheorghe, Dora Maria Popescu, Alex Salan, Mihail Virgil Boldeanu, Claudiu Marinel Ionele, Allma Pitru, Adina Turcu-Stiolica, Adrian Camen, Cristina Florescu, Ion Rogoveanu, Petra Surlin

Abstract

Non-surgical periodontal therapy (NSPT) is the first essential step for the management of any periodontitis patient. This study aims to evaluate the impact of NSPT on pro-inflammatory mediators' regulation and on clinical parameters in periodontitis patients who suffer from chronic hepatitis C. At baseline, selected patients were clinically evaluated for their periodontal status. A subsequent quantitative assessment of C-reactive protein and pentraxin-3 in samples of gingival fluid was performed by Enzyme-Linked Immunosorbent Assay (ELISA). Afterwards, NSPT was performed. Three months after NSPT, the clinical and ELISA assessments were repeated. The results show an improvement of the clinical parameters in periodontitis patients at the three-month recall. In chronic hepatitis C patients with periodontitis, the gingival fluid levels of pro-inflammatory markers reduced significantly. The targeted markers also expressed significant correlations with the clinical parameters used for the assessment of periodontitis' severity. The results suggest that, while chronic hepatitis C patients exhibited a more negative periodontal status at baseline as compared to non-hepatitis ones, NSPT is effective in decreasing the local periodontal inflammatory reaction and in proving the periodontal status of this type of patients. Given the limitation of the study, periodontal screening and NSPT should be included in the integrated therapeutical approach of chronic hepatitis C patients, for its impact on the local inflammatory response.

Keywords: c-reactive protein; chronic hepatitis C; enzyme-linked immunosorbent assay; gingival fluid; non-surgical periodontal therapy; pentraxin-3; periodontitis.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Heatmap of the correlation matrix for every group of patients before the treatment: HCVP1 = HCV+P group at baseline; P1 = P group at baseline; H1 = H group at baseline; hs-CRP = high-sensitivity C-reactive protein; PTX3 = pentraxin-3.
Figure 2
Figure 2
Heatmap of the correlation matrix for every group of patients after the treatment: HCVP2 = HCV+P group at recall; P2 = P group at recall; H2 = H group at recall.
Figure 3
Figure 3
Levels of clinical and immunologic parameters baseline vs. recall. HCVP1 = HCV+P group baseline; HCVP2 = HCV group recall; P1 = P group baseline; P2 = P group recall; H1 = H group baseline; H2 = H group recall. (A) Mean probing depth. (B) Mean attachment level. (C) Plaque. (D) Bleeding on probing. (E) hs-CRP. (F) PTX3. Data were analyzed for statistical significance using Mann-Whitney tests between groups. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001; ns = not significantly different.
Figure 3
Figure 3
Levels of clinical and immunologic parameters baseline vs. recall. HCVP1 = HCV+P group baseline; HCVP2 = HCV group recall; P1 = P group baseline; P2 = P group recall; H1 = H group baseline; H2 = H group recall. (A) Mean probing depth. (B) Mean attachment level. (C) Plaque. (D) Bleeding on probing. (E) hs-CRP. (F) PTX3. Data were analyzed for statistical significance using Mann-Whitney tests between groups. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001; ns = not significantly different.

References

    1. Schaudinn C., Gorur A., Keller D., Sedghizadeh P.P., Costerton J.W. Periodontitis: An archetypical biofilm disease. J. Am. Dent. Assoc. 2009;140:978–986. doi: 10.14219/jada.archive.2009.0307.
    1. Costalonga M., Herzberg M.C. The oral microbiome and the immunobiology of periodontal disease and caries. Immunol. Lett. 2014;162:22–38. doi: 10.1016/j.imlet.2014.08.017.
    1. Takahashi N. Oral microbiome metabolism: From “who are they?” to “what are they doing?”. J. Dent Res. 2015;94:1628–1637.
    1. Maddi A., Scannapieco F.A. Oral biofilms, oral and periodontal infections, and systemic disease. Am. J. Dent. 2013;26:249–254.
    1. Otomo-Corgel J., Pucher J.J., Rethman M.P., Reynolds M.A. State of the science: Chronic periodontitis and systemic health. J. Evid. Based Dent. Pract. 2012;12:20–28. doi: 10.1016/S1532-3382(12)70006-4.
    1. Katz J., Wallet S., Cha S. Periodontal disease and the oral-systemic connection: “Is it all the RAGE?”. Quintessence Int. 2010;41:229–237.
    1. Seymour G.J., Ford P.J., Cullinan M.P., Leishman S., Yamazaki K. Relationship between periodontal infections and systemic disease. Clin. Microbiol. Infect. 2007;13:3–10. doi: 10.1111/j.1469-0691.2007.01798.x.
    1. Williams R.C., Offenbacher S. Periodontal medicine: The emergence of a new branch of periodontology. Periodontol. 2000. 2000;23:9–12. doi: 10.1034/j.1600-0757.2000.2230101.x.
    1. Linden G.J., Lyons A., Scannapieco F.A. Periodontal systemic associations: Review of the evidence. J. Clin. Periodontol. 2013;40((Suppl. 14)):S8–S19. doi: 10.1111/jcpe.12064.
    1. Tonetti M.S., Greenwell H., Kornman K.S. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J. Periodontol. 2018;89:S159–S172. doi: 10.1002/JPER.18-0006.
    1. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., AlMazroa M.A. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. doi: 10.1016/S0140-6736(12)61728-0.
    1. van der Meer A.J., Veldt B.J., Feld J.J., Wedemeyer H., Dufour J.F., Lammert F., Zeuzem S. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308:2584–2593. doi: 10.1001/jama.2012.144878.
    1. Maheshwari A., Ray S., Thuluvath P.J. Acute hepatitis C. Lancet. 2008;372:321–332. doi: 10.1016/S0140-6736(08)61116-2.
    1. Westbrook R.H., Dusheiko G. Natural history of hepatitis C. J. Hepatol. 2014;61:S58–S68. doi: 10.1016/j.jhep.2014.07.012.
    1. Rosen H.R. Chronic hepatitis C infection. N. Engl. J. Med. 2011;364:2429–2438. doi: 10.1056/NEJMcp1006613.
    1. Koretz R.L. Most Patients with Hepatitis C will Die with their Disease. Clin. Dilemmas Viral Liver Dis. 2010;51:249–251.
    1. Gupta G. Gingival crevicular fluid as a periodontal diagnostic indicator- II: Inflammatory mediators, host-response modifiers and chair side diagnostic aids. J. Med. Life. 2013;6:7–13.
    1. Surlin P., Gheorghe D.N., Popescu D.M., Martu A.M., Solomon S., Roman A., Rogoveanu I. Interleukin-1α and-1β assessment in the gingival crevicular fluid of periodontal patients with chronic hepatitis C. Exp. Ther. Med. 2020;20:2381–2386. doi: 10.3892/etm.2020.8906.
    1. Du Clos T.W. Pentraxins: Structure, function, and role in inflammation. Int. Sch. Res. Not. 2013:379040. doi: 10.1155/2013/379040.
    1. Pradeep A.R., Kathariya R., Raghavendra N.M., Sharma A. Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease. J. Periodontol. 2011;82:734–741. doi: 10.1902/jop.2010.100526.
    1. Pradeep A.R., Manjunath R.G., Kathariya R. Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levels. J. Investig. Clin. Dent. 2010;1:133–138. doi: 10.1111/j.2041-1626.2010.00022.x.
    1. Tasdemir Z., Özsarı Tasdemir F., Gürgan C., Eroglu E., Gunturk I., Kocyigit I. The effect of periodontal disease treatment in patients with continuous ambulatory peritoneal dialysis. Int. Urol. Nephrol. 2018;50:1519–1528. doi: 10.1007/s11255-018-1913-y.
    1. Mohan M., Jhingran R., Bains V.K., Gupta V., Madan R., Rizvi I., Mani K. Impact of scaling and root planing on C-reactive protein levels in gingival crevicular fluid and serum in chronic periodontitis patients with or without diabetes mellitus. J. Periodontal. Implant. Sci. 2014;44:158–168. doi: 10.5051/jpis.2014.44.4.158.
    1. Gümüş P., Nizam N., Nalbantsoy A., Özçaka Ö., Buduneli N. Saliva and serum levels of pentraxin-3 and interleukin-1β in generalized aggressive or chronic periodontitis. J. Periodontol. 2014;85:e40–e46. doi: 10.1902/jop.2013.130281.
    1. Fujita Y., Ito H., Sekino S., Numabe Y. Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Odontology. 2012;100:215–221. doi: 10.1007/s10266-011-0042-1.
    1. Çalapkorur M.U., Alkan B.A., Tasdemir Z., Akcali Y., Saatçi E. Association of peripheral arterial disease with periodontal disease: Analysis of inflammatory cytokines and an acute phase protein in gingival crevicular fluid and serum. J. Periodontal. Res. 2017;52:532–539. doi: 10.1111/jre.12419.
    1. Temelli B., Yetkin Ay Z., Savaş H.B., Aksoy F., Kumbul Doğuç D., Uskun E., Varol E. Circulation levels of acute phase proteins pentraxin 3 and serum amyloid A in atherosclerosis have correlations with periodontal inflamed surface area. J. Appl. Oral Sci. 2018;26:e20170322. doi: 10.1590/1678-7757-2017-0322.
    1. Nerkiz P., Doganer Y.C., Aydogan U., Akbulut H., Parlak A., Aydogdu A., Sari O., Cayci T., Barcin C., Koc B. Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis. Med. Princ. Pract. 2015;24:369–375. doi: 10.1159/000381879.
    1. Mathew V., Varghese S., Sankari M., Jayakumar N.D. Evaluation of pentraxin 3 in chronic periodontitis patients before and after the treatment. Int. J. Med. Exerc. Sci. 2015;1:9–15. doi: 10.36678/ijmaes.2015.v01i01.002.
    1. Tasdemir Z., Oskaybas M.N., Alkan A.B., Cakmak O. The effects of ozone therapy on periodontal therapy: A randomized placebo-controlled clinical trial. Oral. Dis. 2019;25:1195–1202. doi: 10.1111/odi.13060.
    1. Singh P., Tushar , Sharma S., Anand K., Kumar A., Nezam S. Evaluation of Inflammatory Acute Phase Protein Level and Different Leukocyte Counts in Chronic Periodontitis Normolipidemic Patients after Nonsurgical Periodontal Therapy. J. Contemp. Dent. Pract. 2021;22:373–377.
    1. Bian Y., Liu C., Fu Z. Application value of combination therapy of periodontal curettage and root planing on moderate-to-severe chronic periodontitis in patients with type 2 diabetes. Head. Face. Med. 2021;17:12. doi: 10.1186/s13005-020-00253-z.
    1. Baser U., Oztekin G., Ademoglu E., Isik G., Yalcin F. Is the severity of periodontitis related to gingival crevicular fluid and serum high-sensitivity C-reactive protein concentrations? Clin. Lab. 2014;60:1653–1658. doi: 10.7754/Clin.Lab.2014.131217.
    1. Sun J., Zheng Y., Bian X., Ge H., Wang J., Zhang Z. Non-surgical periodontal treatment improves rheumatoid arthritis disease activity: A meta-analysis. Clin. Oral. Investig. 2021;25:4975–4985. doi: 10.1007/s00784-021-03807-w.
    1. Ahluwalia S., Choudhary D., Tyagi P., Kumar V., Vivekanandan P. Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter. J. Biol. Chem. 2021;297:101233. doi: 10.1016/j.jbc.2021.101233.
    1. Costantini E., Sinjari B., Piscopo F., Porreca A., Reale M., Caputi S., Murmura G. Evaluation of Salivary Cytokines and Vitamin D Levels in Periodontopathic Patients. Int. J. Mol. Sci. 2020;21:2669. doi: 10.3390/ijms21082669.
    1. Doica I.P., Florescu D.N., Oancea C.N., Turcu-Stiolica A., Subtirelu M.S., Dumitra G., Rogoveanu I., Gheonea D.I., Ungureanu B.S. Telemedicine Chronic Viral Hepatitis C Treatment during the Lockdown Period in Romania: A pilot study. Int. J. Environ. Res. 2021;18:3694. doi: 10.3390/ijerph18073694.
    1. Sinjari B., D’Addazio G., Bozzi M., Celletti R., Traini T., Mavriqi L., Caputi S. Comparison of a Novel Ultrasonic Scaler Tip vs. Conventional Design on a Titanium Surface. Materials. 2018;11:2345. doi: 10.3390/ma11122345.

Source: PubMed

3
订阅